Jump to navigation

Navigation
  • Sign in

Search form

Top Menu

  • Newsletters
  • Español
Home
  • Español
  • About the Study
  • Virtual TownHall
  • FAQ
  • For Providers
  • For Participants
Find your study site

California

  • UCLA CARE Center and Clinic
  • UCSF Mt. Zion Medical Center

Colorado

  • Denver Public Health
  • University of Colorado Denver

DC

  • Dupont Circle Physicians Group
  • Washington DC - Capital Digestive Care

Florida

  • University of Miami Health System

Georgia

  • Emory University - Grady Hospital

Illinois

  • Anal Dysplasia Clinic Midwest

Louisiana

  • Louisiana State University

Massachusetts

  • Boston Medical Center

New Jersey

  • NJMS Clinical Research Unit

New York

  • Cornell Clinical Trials Unit
  • Laser Surgery Care
  • Montefiore Medical Center

North Carolina

  • Wake Forest Baptist Medical Center

Puerto Rico

  • University of Puerto Rico

Washington

  • Harborview Medical Center
  • Virginia Mason Medical Center

Don't see your state?

  • Find out why
  • About the Study
    •  < Back
    • The ANCHOR Study
    • Community Advisory Board
    • Meet the National Team
    • Anal Cancer Risk Compared
    • Study News
  • Virtual TownHall
  • FAQ
    •  < Back
    • Frequently Asked Questions"
    • What is HPV?
    • Anal Cancer Basics
    • How is HSIL Treated?
    • How Do I Sign Up?
    • What Risks Are Involved?
    • What is IRC?
  • For Providers
    •  < Back
    • For Providers
    • Why Anchor?
    • What to Tell Patients
    • Evidence & Data
    • Accountability
  • For Participants
    •  < Back
    • For Our Participants
    • Need a Reminder?
    • Let's Talk
    • Newsletter

Search form

  • Newsletters
  • The ANCHOR Study
  • Community Advisory Board
  • Meet the National Team
  • Anal Cancer Risk Compared
  • Study News
  • Frequently Asked Questions"
  • What is HPV?
  • Anal Cancer Basics
  • How is HSIL Treated?
  • How Do I Sign Up?
  • What Risks Are Involved?
  • What is IRC?
  • Atlanta - Emory
  • Boston Medical Center
  • Chicago - Midwest
  • Denver - Public Health
  • Denver - U. Colorado Denver
  • DC - Capital Digestive Care
  • DC - Dupont Circle
  • LA - UCLA Care Center
  • LA - UCLA School of Nursing
  • Miami
  • NOLA - Crescent Care
  • NOLA - LSU
  • NY - Cornell
  • NY - Laser Surgery Care
  • NY - Montefiore
  • Puerto Rico
  • San Francisco
  • Seattle - Harborview
  • Seattle - Polyclinic
  • Seattle - Virginia Mason
  • Winston-Salem
  • For Our Participants
  • Need a Reminder?
  • Let's Talk
  • Newsletter
  • For Providers
  • Why Anchor?
  • What to Tell Patients
  • Evidence & Data
  • Accountability

ANCHOR Study Showed that Treatment Can Prevent Anal Cancer!

Treating anal cancer precursor lesions reduces cancer risk for people living with HIV. The Study’s results have been published in peer-reviewed publications. Because of the public health importance of the findings, the Centers for Disease Control now recommends that people with HIV be screened for anal cancer.

  • Read the study's press release
  • How does this affect participants?
  • Read the guidelines press release
  • Read the CDC guidelines

A big "Thank you!" from our National Team and study sites!

Anchor Study National Team
Anchor Study National Team
Anal Dysplasia Clinic Midwest
Anal Dysplasia Clinic Midwest
NYC Laser Surgery Care
NYC Laser Surgery Care
Denver Public Health
Denver Public Health
Louisiana State University
Louisiana State University
University of Miami Health System
University of Miami Health System
NC Wake Forest Baptist Medical Center
NC Wake Forest Baptist Medical Center
Virginia Mason Medical Center
Virginia Mason Medical Center
Dupont Circle Physicians Group and Capital Digestive Care
Dupont Circle Physicians Group and Capital Digestive Care
ANCHOR Study Biorepository
ANCHOR Study Biorepository
Latest News in the Study: 

JAMA Insights: Prevention of Anal Cancer in High-Risk Individuals

10/23/24

This JAMA Insights examines the treatment and rising prevalence of anal cancer in the US in high-risk groups, including people with HIV and

Watch: Queer News Today on the New CDC Guidelines for Anal Cancer Screening

07/25/24

Watch this video to review this news outlet’s coverage of new Federal guidelines to combat anal cancer among individuals with HIV, marking the

UCSF Press Release on CDC’s Anal Cancer Screening Guidelines for People with HIV

07/18/24

These new recommendations for screening and treatment are based on the results of the ANCHOR Study.

View All

Learn More About This National Study

Frequently Asked Questions
Information on Anal Cancer
Meet the Researchers
Why This Study is Historic

"ANCHOR data show for the first time that, like cervical cancer, anal cancer can be prevented even in high-risk populations, such as people living with HIV, who often have HSIL that can be difficult to treat."

- Dr. Joel Palefsky, Principal Investigator
Contact the National Study Investigators
844-448-2888
AMC
This study is funded by a grant from the
National Cancer Institute of the National Institutes of Health
under an award to the AIDS Malignancy Consortium.

Privacy PolicyTerms of Use
© 2024 The Anchor Study